Viewing nowCombinationPocidime Sustained Release Tablet 5/500 mg
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
Kukje Pharm Co., Ltd.

MFDS item code 202300273 · Approved 2023.01.17 · Insurance code 643705410
Improvement of glycemic control in adults with type 2 diabetes
This drug helps improve blood sugar control when used in conjunction with dietary and exercise regimens for adults with poorly controlled type 2 diabetes. It can also be used for patients with cardiovascular disease or cardiovascular risk factors, and it is important to consult a specialist for information on the occurrence of cardiovascular events. Therefore, this drug assists with blood sugar control in type 2 diabetes patients and contributes to the management of cardiovascular risk.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose glycemic control is inadequate with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions from metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the dose of metformin the patient was taking or an appropriate dose therapeutically close to it. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately. For patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment may be started at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from another antihyperglycemic agent. Because changes may cause alterations in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under careful monitoring. This medicine must be swallowed whole and must not be crushed, cut, or chewed. Occasionally, the inactive ingredients of this medicine may be excreted in the stool as a soft, hydrated mass resembling the tablet. Renal impairment No dose adjustment is required in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher but below 60 mL/min/1.73 m2, and who have no other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this medicine must be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted by the kidneys and renal function tends to decline in elderly patients, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).
This drug helps control blood sugar. However, there are several precautions to consider when taking this medication. First, this drug can rarely cause a serious condition called lactic acidosis. Lactic acidosis is a dangerous condition that occurs when there is an excessive accumulation of lactic acid in the body, which can be life-threatening, so any symptoms should prompt immediate consultation with a physician. In addition, caution is warranted when used with other diabetes medications such as insulin or sulfonylureas, as the risk of hypoglycemia may increase. Patients with poor kidney function, dehydration, serious infections, or impaired cardiac function should not take this medication. It is especially recommended that this drug not be used in cases of moderate to severe renal impairment. Additionally, this medication should not be used by pregnant or breastfeeding women, nor by patients with lactose intolerance. During treatment, symptoms of decreased fluid volume or hypotension may occur, so elderly patients or those taking diuretics should regularly monitor blood pressure and fluid status. This medication can increase the risk of infections like genital and urinary tract infections, so prompt treatment should be sought for any related symptoms. Furthermore, it may lower vitamin B12 levels, necessitating regular blood tests for prolonged use. Avoiding alcohol is advisable while taking this medication, as it may increase the risk of side effects. Before undergoing surgery or imaging procedures that use iodinated contrast agents, it is necessary to discontinue this medication for a period, so consultation with healthcare providers is essential. Finally, this medication should be used cautiously in children and the elderly, with particular monitoring of renal function in older patients. Regular assessment of renal function and blood sugar status according to a physician's instructions is important during treatment.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a room temperature between 1 and 30 degrees Celsius.
Orange rectangular sustained-release film-coated tablet
30 tablets/box [(6 tablets/PTP) X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
Kukje Pharm Co., Ltd.
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.